A detailed history of Caption Management, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 302,200 shares of ITOS stock, worth $2.42 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
302,200
Previous 19,000 1490.53%
Holding current value
$2.42 Million
Previous $281,000 997.86%
% of portfolio
0.05%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.33 - $18.09 $196,270 - $343,710
19,000 New
19,000 $281,000
Q2 2022

Aug 15, 2022

BUY
$16.57 - $35.1 $125,932 - $266,760
7,600 Added 42.22%
25,600 $527,000
Q1 2022

May 13, 2022

BUY
$31.92 - $47.45 $574,560 - $854,100
18,000 New
18,000 $579,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $285M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.